BRWM
GSK icon

B. Riley Wealth Management’s GSK GSK Stock Holding History

B. Riley Wealth Management’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-4,981
Closed -$271K – 776
2022
Q1 		$271K Buy
4,981
+18
+0.4% +$978 0.02% 481
2021
Q4 		$274K Buy
4,963
+20
+0.4% +$1.04K 0.02% 497
2021
Q3 		$236K Sell
4,943
-1,057
-18% -$53.1K 0.02% 517
2021
Q2 		$299K Sell
6,000
-2,065
-26% -$99.2K 0.03% 315
2021
Q1 		$360K Sell
8,065
-1,544
-16% -$70.1K 0.04% 268
2020
Q4 		$442K Sell
9,609
-4,214
-30% -$194K 0.06% 219
2020
Q3 		$650K Buy
13,823
+2,051
+17% +$103K 0.08% 195
2020
Q2 		$600K Sell
11,772
-2,124
-15% -$109K 0.07% 207
2020
Q1 		$658K Buy
13,896
+6,002
+76% +$320K 0.07% 238
2019
Q4 		$464K Sell
7,894
-1,800
-19% -$100K 0.07% 220
2019
Q3 		$517K Sell
9,694
-336
-3% -$17.3K 0.09% 200
2019
Q2 		$502 Sell
10,030
-1,304
-12% -$65.4K 0.08% 208
2019
Q1 		$592K Buy
11,334
+2,193
+24% +$110K 0.1% 191
2018
Q4 		$437K Buy
9,141
+1,008
+12% +$49.6K 0.09% 196
2018
Q3 		$408K Buy
+8,133
New +$413K 0.1% 172
2015
Q3 		– Sell
-2,910
Closed -$151K – 383
2015
Q2 		$151K Sell
2,910
-1,268
-30% -$71.4K 0.12% 217
2015
Q1 		$241K Buy
4,178
+20
+0.5% +$1.15K 0.18% 166
2014
Q4 		$222K Buy
4,158
+1,772
+74% +$99.1K 0.18% 142
2014
Q3 		$137K Buy
2,386
+572
+32% +$35.1K 0.1% 243
2014
Q2 		$121K Buy
1,814
+814
+81% +$55.1K 0.08% 315
2014
Q1 		$67K Buy
+1,000
New +$67.6K 0.05% 392

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Parallax Volatility Advisers
Parallax Volatility Advisers San Francisco, California $38.6B AUM 45.89% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return

B. Riley Wealth Management's GSK Position: Q2 2022 in Review

B. Riley Wealth Management sold out of GSK (GSK) in Q2 2022, closing a stake of 4,981 shares — an estimated $271K sold.

B. Riley Wealth Management first reported a position in GSK in Q1 2014 and held it in 21 quarters. The position peaked at $658K in Q1 2020. 900 funds tracked by Wall St. Rank hold GSK as of Q2 2022.

  • B. Riley Wealth Management reported no remaining GSK position as of Q2 2022 after selling out during the quarter.
  • B. Riley Wealth Management sold 4,981 GSK shares in Q2 2022, an estimated $271K.
  • B. Riley Wealth Management first reported a position in GSK in Q1 2014 and held it in 21 quarters.
  • B. Riley Wealth Management's GSK position peaked at $658K in Q1 2020.
  • 900 funds tracked by Wall St. Rank held GSK as of Q2 2022.

Based on B. Riley Wealth Management's 13F filing for Q2 2022, filed 9 Sep 2022.